APA

Boland G. M., Piha-Paul S. A., Subbiah V., Routbort M., Herbrich S. M., Baggerly K., Patel K. P., Brusco L., Horombe C., Naing A., Fu S., Hong D. S., Janku F., Johnson A., Broaddus R., Luthra R., Shaw K., Mendelsohn J., Mills G. B. & Meric-Bernstam F. (20160714). Clinical next generation sequencing to identify actionable aberrations in a phase I program. : Oncotarget.

Chicago

Boland Genevieve M, Piha-Paul Sarina A, Subbiah Vivek, Routbort Mark, Herbrich Shelley M, Baggerly Keith, Patel Keyur P, Brusco Lauren, Horombe Chacha, Naing Aung, Fu Siqing, Hong David S, Janku Filip, Johnson Amber, Broaddus Russell, Luthra Raja, Shaw Kenna, Mendelsohn John, Mills Gordon B and Meric-Bernstam Funda. 20160714. Clinical next generation sequencing to identify actionable aberrations in a phase I program. : Oncotarget.

Harvard

Boland G. M., Piha-Paul S. A., Subbiah V., Routbort M., Herbrich S. M., Baggerly K., Patel K. P., Brusco L., Horombe C., Naing A., Fu S., Hong D. S., Janku F., Johnson A., Broaddus R., Luthra R., Shaw K., Mendelsohn J., Mills G. B. and Meric-Bernstam F. (20160714). Clinical next generation sequencing to identify actionable aberrations in a phase I program. : Oncotarget.

MLA

Boland Genevieve M, Piha-Paul Sarina A, Subbiah Vivek, Routbort Mark, Herbrich Shelley M, Baggerly Keith, Patel Keyur P, Brusco Lauren, Horombe Chacha, Naing Aung, Fu Siqing, Hong David S, Janku Filip, Johnson Amber, Broaddus Russell, Luthra Raja, Shaw Kenna, Mendelsohn John, Mills Gordon B and Meric-Bernstam Funda. Clinical next generation sequencing to identify actionable aberrations in a phase I program. : Oncotarget. 20160714.